The 4-year-old Coalition for the Advancement of Prosthetic Urology(CAPU) is continuing to push for improved funding for penileprostheses and procedures, but the fight is likely to get steeper,according to information CAPU members were given at a meetingyesterday.
The 4-year-old Coalition for the Advancement of Prosthetic Urology (CAPU) is continuing to push for improved funding for penile prostheses and procedures, but the fight is likely to get steeper, according to information CAPU members were given at a meeting yesterday.
John J. Mulcahy, MD, PhD, CAPU chairman, told the attendees that the organization intended to draw as many of its members and supporters as possible to Washington, D.C., the week after Prostate Cancer Awareness Week (Sept. 17-23) to lobby senators and congressmen for improved prostheses funding.
"Too many people look at sexual function as recreational and therefore not essential," he said.
He noted that breast reconstruction was largely a cosmetic procedure at one time, but is now considered an important option for emotional recovery from breast cancer. He emphasized that the organization's efforts were to seek equality for men, not special treatment.
The twin goals of this year's lobbying campaign are to improve Medicare fees for penile prosthetics and procedures and expand private insurance coverage. Dr. Mulcahy noted that the majority of legislators were supportive of the endeavor but were hesitant to affix their names to legislation that seemed like an "unfunded mandate."
Four major economic issues are coalescing to affect Medicare fees, according to Robin Hudson, regulatory affairs manager at AUA. These are a 5-year review of physicians due this year; the implementation of the deficit reduction act of 2005; a projected cut in the conversion factor that affects physician fees; and changes in the way practice expense methodologies are determined. The overall impact of these should be an increase in the reimbursements for many procedures, but not necessarily those for penile prosthetics.
Dr. Mulcahy is optimistic that continued efforts by CAPU would eventually lead to improved funding, although those funding improvements will probably come in increments spread over years. He added a certain urgency to his message, noting that the urology workforce was projected to decline in the next 10 years at the same time the infamous baby boomers are scheduled to undergo a record number of prostatectomies for prostate cancer.
Seeds vs. prostatectomy: Long- and short-term side effects differ slightly
March 15th 2007For men with prostate cancer, radiation seed implants may yield a better short-term side effect profile than surgery, but surgery may offer slightly better long-term outcomes, new research from French radiation oncologists indicates.
Brachytherapy offers high 8-year prostate Ca survival rates
February 15th 2007More than 90% of men who receive appropriate radiation dose levels with permanent radiation seed implants to treat their prostate cancer are cured of the disease 8 years after diagnosis, according to a recent study in the International Journal for Radiation Oncology Biology Physics (2007; 67:327-33).
Research on bladder tissue regeneration progresses
February 1st 2007Atlanta-Tissue engineering research has grown by leaps and bounds in the past decade and a half, yielding findings that may someday have a profound impact on the field of pediatric urology. At the 2006 American Academy of Pediatrics Section on Urology annual meeting here, several groups presented cutting-edge data on novel systems for organ generation, including research demonstrating the feasibility of generating a functioning bladder from stem cells.
Radiation therapy combination prolongs long-term cure rate in men with PCa
January 18th 2007Three-fourths of men treated with a combination of radiation seed implants and external beam radiation therapy for prostate cancer are cured of their disease 15 years following their treatment, according to a study published in the International Journal of Radiation Oncology*Biology*Physics (2007; 67:57-64).
Cystectomy outcomes: Does surgeon's age matter?
October 1st 2006Ann Arbor, MI-Surgeon age is not a significant predictor of risk of mortality after cystectomy, according to the results of a recently published study from researchers at the University of Michigan, Ann Arbor (Ann Surg 2006; 244:353-62).